FDA Inspection 1115862 — Robert Wood Johnson University Hospital Somerset
The FDA completed an inspection of Robert Wood Johnson University Hospital Somerset on Jan 16, 2020 in Somerville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 16, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Somerville, NJ (United States)